MAZE logo

Maze Therapeutics, Inc. (MAZE) Cash From Financing

Annual CFF:

$92.85M+$76.46M(+466.66%)
December 31, 2024

Summary

  • As of today, MAZE annual cash from financing is $92.85 million, with the most recent change of +$76.46 million (+466.66%) on December 31, 2024.
  • During the last 3 years, MAZE annual cash from financing has risen by +$91.12 million (+5273.09%).
  • MAZE annual cash from financing is now at all-time high.

Performance

1-Year Change

+466.66%

3-Year Change

+5273.09%

5-Year Change

+5273.09%

15-Year Change

+5273.09%

MAZE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

81.08%
MAZE annual cash from financing is higher than 81.08% of companies in Healthcare sector

Range

All-Time High

$92.85M
MAZE annual cash from financing is currently at an all-time high

3-Year Low

$1.73M
MAZE annual cash from financing is currently +5273.09% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MAZE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 5, 2026
MAZE next annual earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Annual CFI

-$1.15M
MAZE annual cash from investing is -$1.15 million

Annual CFO

$75.95M
MAZE annual cash from operations is $75.95 million

Annual FCF

$74.81M
MAZE annual free cash flow is $74.81 million

Annual CAPEX

$1.15M
MAZE annual capital expenditures is $1.15 million

Quarterly CFF:

$143.76M+$143.15M(+23389.71%)
September 30, 2025

Summary

  • As of today, MAZE quarterly cash from financing is $143.76 million, with the most recent change of +$143.15 million (+23389.71%) on September 30, 2025.
  • MAZE quarterly cash from financing is now at all-time high.

Performance

3-Month Change

+23389.71%

1-Year Change

-

3-Year Change

+72873.1%

5-Year Change

+72873.1%

MAZE Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.81%
MAZE quarterly cash from financing is higher than 95.81% of companies in Healthcare sector

Range

All-Time High

$143.76M
MAZE quarterly cash from financing is currently at an all-time high

3-Year Low

$197.00K
MAZE quarterly cash from financing is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Quarterly CFI

-$66.88M
MAZE quarterly cash from investing is -$66.88 million

Quarterly CFO

-$24.64M
MAZE quarterly cash from operations is -$24.64 million

Quarterly FCF

-$24.71M
MAZE quarterly free cash flow is -$24.71 million

Quarterly CAPEX

$68.00K
MAZE quarterly capital expenditures is $68.00 thousand

TTM CFF:

$342.01M+$143.76M(+72.51%)
September 30, 2025

Summary

  • As of today, MAZE TTM cash from financing is $342.01 million, with the most recent change of +$143.76 million (+72.51%) on September 30, 2025.
  • MAZE TTM cash from financing is now at all-time high.

Performance

3-Month Change

+72.51%

1-Year Change

-

3-Year Change

+173508.63%

5-Year Change

+173508.63%

MAZE TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.35%
MAZE TTM cash from financing is higher than 96.35% of companies in Healthcare sector

Range

All-Time High

$342.01M
MAZE TTM cash from financing is currently at an all-time high

3-Year Low

$197.00K
MAZE TTM cash from financing is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

TTM CFI

-$68.18M
MAZE TTM cash from investing is -$68.18 million

TTM CFO

-$106.66M
MAZE TTM cash from operations is -$106.66 million

TTM FCF

-$108.03M
MAZE TTM free cash flow is -$108.03 million

TTM CAPEX

$1.36M
MAZE TTM capital expenditures is $1.36 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

MAZE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+466.7%--
3Y3 Years+5273.1%+10000.0%+10000.0%
5Y5 Years+5273.1%+10000.0%+10000.0%

MAZE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+5273.1%at high>+9999.0%at high>+9999.0%
5Y5-Yearat high+5273.1%at high>+9999.0%at high>+9999.0%
All-TimeAll-Timeat high+5273.1%at high>+9999.0%at high>+9999.0%

MAZE Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$143.76M(>+9900.0%)
$342.01M(+72.5%)
Jun 2025
-
$612.00K(-99.5%)
$198.25M(+0.3%)
Mar 2025
-
$127.38M(+81.3%)
$197.64M(+108.4%)
Dec 2024
$92.85M
$70.26M(+185.8%)
$94.84M(+131.5%)
DateAnnualQuarterlyTTM
Mar 2024
-
$24.58M(+51.8%)
$40.97M(+150.0%)
Dec 2023
$16.39M(+848.2%)
$16.19M(+8117.3%)
$16.39M(+8217.3%)
Sep 2023
-
$197.00K
$197.00K
Dec 2022
$1.73M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual cash from financing year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Maze Therapeutics, Inc.?

What is Maze Therapeutics, Inc. annual cash from financing?

The current annual cash from financing of MAZE is $92.85M

What is the all-time high annual cash from financing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual cash from financing is $92.85M

What is Maze Therapeutics, Inc. annual cash from financing year-on-year change?

Over the past year, MAZE annual cash from financing has changed by +$76.46M (+466.66%)

What is Maze Therapeutics, Inc. quarterly cash from financing?

The current quarterly cash from financing of MAZE is $143.76M

What is the all-time high quarterly cash from financing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly cash from financing is $143.76M

What is Maze Therapeutics, Inc. TTM cash from financing?

The current TTM cash from financing of MAZE is $342.01M

What is the all-time high TTM cash from financing for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM cash from financing is $342.01M
On this page